Conquering Diseases

Investigational Drug Study For Patients With Rheumatoid Arthritis

Description

Seeking Men and Women 18 years or older who have completed a Gilead sponsored filgotinib parent study for RA GS-US-417-0303 for the treatment of Rheumatoid Arthritis (RA),

Overview

The purpose of this study is to see if filgotinib (study drug) can be safe and useful in the long-term treatment of Rheumatoid Arthritis.

What we're hoping for

The results and information obtained from this study may help others in the future.

Additional Information

ClinicalTrials.gov Identifier: NCT03025308

 Principal Investigator

Jonathan  Kay, MD

UMass Memorial Health Care

 Study Contact

Steven  Ball

508-334-0221

Steven.Ball@umassmed.edu

 Location

UMMHC Memorial Campus

281 Lincoln St. 

Worcester,MA 01605

508-334-1000